- Home
- CODA vs ENTX Comparison
CODA vs ENTX Comparison
Compare CODA & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- ENTX
- Stock Information
- Founded
- CODA 1994
- ENTX 2010
- Country
- CODA United States
- ENTX Israel
- Employees
- CODA N/A
- ENTX N/A
- Industry
- CODA Industrial Machinery/Components
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CODA Industrials
- ENTX Health Care
- Exchange
- CODA Nasdaq
- ENTX Nasdaq
- Market Cap
- CODA 88.7M
- ENTX 104.0M
- IPO Year
- CODA N/A
- ENTX 2018
- Fundamental
- Price
- CODA $8.25
- ENTX $1.99
- Analyst Decision
- CODA Strong Buy
- ENTX Strong Buy
- Analyst Count
- CODA 1
- ENTX 1
- Target Price
- CODA $11.00
- ENTX $10.00
- AVG Volume (30 Days)
- CODA 62.3K
- ENTX 37.1K
- Earning Date
- CODA 06-16-2025
- ENTX 08-08-2025
- Dividend Yield
- CODA N/A
- ENTX N/A
- EPS Growth
- CODA 21.86
- ENTX N/A
- EPS
- CODA 0.30
- ENTX N/A
- Revenue
- CODA $22,758,966.00
- ENTX $223,000.00
- Revenue This Year
- CODA $11.64
- ENTX N/A
- Revenue Next Year
- CODA $14.53
- ENTX N/A
- P/E Ratio
- CODA $27.03
- ENTX N/A
- Revenue Growth
- CODA 24.78
- ENTX N/A
- 52 Week Low
- CODA $5.76
- ENTX $1.41
- 52 Week High
- CODA $9.89
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- CODA 65.45
- ENTX 49.71
- Support Level
- CODA $7.60
- ENTX $1.91
- Resistance Level
- CODA $8.10
- ENTX $2.06
- Average True Range (ATR)
- CODA 0.65
- ENTX 0.17
- MACD
- CODA 0.10
- ENTX -0.00
- Stochastic Oscillator
- CODA 77.76
- ENTX 36.36
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.